Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-27T06:16:34.789Z Has data issue: false hasContentIssue false
  • English
  • Français

Glutamate Dehydrogenase Deficiency in Machado-Joseph Disease

Published online by Cambridge University Press:  18 September 2015

A. Gonçalves ,
C. Oliveira ,
M.A. Ferro ,
M. Dinis  and
L. Cunha
A. Gonçalves*
Affiliation:
Clinica Neurológica dos Hospitals da Universidade de Coimbra, Coimbra, Portugal
C. Oliveira
Affiliation:
Clinica Neurológica dos Hospitals da Universidade de Coimbra, Coimbra, Portugal
M.A. Ferro
Affiliation:
Clinica Neurológica dos Hospitals da Universidade de Coimbra, Coimbra, Portugal
M. Dinis
Affiliation:
Clinica Neurológica dos Hospitals da Universidade de Coimbra, Coimbra, Portugal
L. Cunha
Affiliation:
Clinica Neurológica dos Hospitals da Universidade de Coimbra, Coimbra, Portugal
*
Clinica Neurológica, Hospitais da Universidade de Coimbra, Av. Bissaya Barreto, 3049 Coimbra Codex, Portugal
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We studied the activity of glutamate dehydrogenase (GDH) in leukocytes from 23 patients with domi-nantly inherited ataxia. All the patients were assessed with a rating scale for ataxias and met the clinical criteria for the diagnosis of Machado-Joseph disease. The mean age of onset of symptoms was 37.8, SD 13.4 years and the duration of the disease was 7.4, SD 4.9. Leukocyte GDH activity was significantly decreased (p < 0.001) when compared to 20 normal controls. These data extend previous reports indicating that a GDH deficiency is present in peripheral tissues from some patients with spinocerebellar degenerations. Furthermore, this study suggests that a genetic deficiency of GDH may underlie some forms of dominant ataxias; this deficiency may be marked in patients with Machado-Joseph disease and is not specific for any type of multiple system atrophy.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 20 , Issue 2 , May 1993 , pp. 147 - 150
Copyright
Copyright © Canadian Neurological Sciences Federation 1993

References

1.Harding, A. The hereditary ataxias and related disorders. In: Glaser, G, Barbeau, A, Barnett, H, Collins, W, eds. Clinical Neurology and Neurosurgery Monographs. Vol. 6. Churchill Livingstone 1984.Google Scholar
2.Blass, J. Hereditary ataxias. In: Current Neurology. John Wiley and Sons, eds., New York 1981: 66–91.Google Scholar
3.Perry, T, Currier, O, Hansen, S, MacLean, J. Aspartate-taurine imbalance in dominantly inherited olivopontocerebellar atrophy. Neurology 1977; 27: 257–261.CrossRefGoogle ScholarPubMed
4.Perry, T, Hansen, S, Currier, R, Berry, K. Abnormalities in neurotransmitter AA in dominantly inherited cerebellar disorders. In: Kark, R, Rosenberg, R, Schut, L, eds. Adv Neurol, Vol 21. The Inherited Ataxias. New York: Raven Press 1978: 303–314.Google Scholar
5.Perry, T, Kish, S, Hansen, S, Currier, R. Neurotransmitter AA in dominantly inherited cerebellar disorders. Neurology 1981; 31: 237–242.CrossRefGoogle Scholar
6.Perry, T. Four biochemically different types of dominantly inherited OPCA. In: Duvoisin, R, Plaitakis, A, eds. Adv Neurol, Vol 41. The Olivopontocerebellar Atrophies. New York: Raven Press 1984; 205–216.Google Scholar
7.McGeer, P, Eccles, J, McGeer, E. Putative excitatory neurons: glutamate and aspartate. In: McGeer, P, Eccles, J, McGeer, E, eds. Molecular Neurobiology of the Mammalian Brain. New York: Plenum Press 1978; 183–197.CrossRefGoogle Scholar
8.Engelsen, B. Neurotransmitter glutamate: its clinical importance. Acta Neurol Scand 1986; 74: 337–355.CrossRefGoogle ScholarPubMed
9.Prusiner, S. Disorders of glutamate metabolism and neurological dysfunction. Ann Rev Med 1981; 32: 521–542.CrossRefGoogle ScholarPubMed
10.Nicklas, W. Amino acid metabolism in the central nervous system: role of glutamate dehydrogenase. In: Duvoisin, R, Plaitakis, A, eds. Adv Neurol, Vol 41. The Olivopontocerebellar Atrophies. New York: Raven Press 1984; 245–253.Google Scholar
11.Finochiaro, G, Taroni, F, Di, Donato S. GDH in OPCA: leucocytes, fibroblasts, and muscle mitochondria. Neurology 1986; 36: 550–553.Google Scholar
12.Sorbi, S, Piacentini, S, Tonini, S. Abnormal GDH activity and activation in dominant and recessive OPCA (abstract). Ann Neurol 1984: 16–136.Google Scholar
13.Sorbi, S, Tonini, S, Giannini, E, et al.Abnormal platelet GDH activity and activation in dominant and nondominant OPCA. Ann Neurol 1986; 19: 239–245.CrossRefGoogle Scholar
14.Barbeau, A, Charbonneau, M, Cloutier, T. Leucocyte glutamate dehydrogenase in various hereditary ataxias. Can J Neurol Sci 1980; 7: 421–424.CrossRefGoogle ScholarPubMed
15.Plaitakis, A, Berl, S, Nicklas, W, Yahr, M. Glutamate dehydrogenase deficiency in spinocerebellar degeneration: correlation with adult-onset recessive ataxia. Trans Am Neurol Assoc 1980; 105: 476–477.Google Scholar
16.Plaitakis, A, Berl, S, Yahr, M. Neurological disorders associated with deficiency of GDH. Ann Neurol 1984; 15: 144–153.CrossRefGoogle Scholar
17.Yamaguchi, T, Hasashi, K, Murakami, H, et al.GDH deficiency in spinocerebellar degenerations. Neurochem Res 1982; 7: 627–636.CrossRefGoogle ScholarPubMed
18.Maruyama, S, Yamaguchi, T. GDH and PDH deficiency in spinocerebellar atrophies. In: Duvoisin, R, Plaitakis, A, eds. Adv Neurol, Vol 41. New York: Raven Press 1984; 252–265.Google Scholar
19.Duvoisin, R, Chokroverty, S, Lepore, F, Nicklas, W. Glutamate dehydrogenase deficiency in patients with olivopontocerebellar atrophy. Neurology 1983; 33: 1322–1327.CrossRefGoogle ScholarPubMed
20.Chokroverty, S, Duvoisin, R, Sachdev, R, et al.Neurophysiologic study of OPCA with or without GDH deficiency. Neurology 1985; 35: 652–659.CrossRefGoogle ScholarPubMed
21.Konagaya, Y, Konagaya, M, Takayanagi, T. GDH and its isozyme activity in OPCA. J Neurol Sci 1986; 74: 231–236.CrossRefGoogle Scholar
22.Cunha, L, Gonçalves, A, Dinis, M, et al.Dominantly inherited ataxias in Portugal. Can J Neurol Sci 1988; 15: 397–401.CrossRefGoogle ScholarPubMed
23.Christhlieb, A, Sbarra, A, Bardawil, N. Isolation of highly purified, viable leucocytes from blood. Am J Clin Pathol 1962; 37: 257–262.CrossRefGoogle Scholar
24.Layne, E. Spectrophotometric and turbidimetric methods for measuring proteins. In: Colowick, S, Kaplan, N, eds. Methods in Enzymology, Vol 3. New York: Academic Press 1957; 447–454.CrossRefGoogle Scholar
25.Lima, L, Coutinho, P. Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorean Portuguese family. Neurology 1980; 30: 319–322.CrossRefGoogle ScholarPubMed
26.Plaitakis, A, Nicklas, W, Desnick, R. GDH deficiency in three patients with spinocebellar syndrome. Ann Neurol 1980; 7: 297–303.CrossRefGoogle Scholar
27.Plaitakis, A, Berl, S, Yahr, M. Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. Science 1982; 216: 193–196.CrossRefGoogle Scholar
28.Sudarsky, L, Shin, V, Mandell, R. Reduced glutamate dehydrogenase activity in Joseph's disease. Neurology 1984; 34: 150.Google Scholar
29.Plaitakis, A, Berl, S, Yahr, M. Neurological disorders associated with deficiency of GDH. Ann Neurol 1984; 15: 144–153.CrossRefGoogle Scholar
30.Aubby, D, Saggu, H, Jenner, P, et al.Leucocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders. J Neurol Neurosurg Psychiatry 1988; 51: 893–902.CrossRefGoogle ScholarPubMed
31.Kajiyama, K, Neno, S, Tatsumi, T, et al.Decreased glutamate dehy-drogenase protein in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry 1988; 51: 1078–1080.CrossRefGoogle Scholar
32.Duvoisin, R, Nicklas, W, Ritchie, V, Sage, J, Chokroverty, S. Low leukocyte glutamate dehydrogenase activity do not correlate with a particular type of multiple system atrophy. J Neurol Neurosurg Psychiatry 1988; 51: 1508–1511.CrossRefGoogle Scholar
33.Orsi, L, Bertolotto, A, Brignolio, F, et al.Glutamate dehydrogenase (GDH) deficiency in different types of progressive hereditary cerebellar ataxia. Acta Neurol Scand 1988; 78: 394–400.CrossRefGoogle ScholarPubMed
34.Tatsumi, C, Yorifuji, K, Kajiyma, K, et al.Glutamate metabolism of leukocyes and skin fibroblasts in spinocerebellar degeneration with lowered glutamate dehydrogenase activity. Acta Neurol Scand 1989; 79: 465–468.CrossRefGoogle Scholar
35.Sorbi, S, Piacentini, S, Fani, C, et al.Abnormalities of mitochondrial enzymes in hereditary ataxias. Acta Neurol Scand 1989; 80: 103–110.CrossRefGoogle ScholarPubMed
36.Kaakkola, S, Marnela, K-M, Oja, S, et al.Leukocyte glutamate dehy-drogenase and CSF amino acids in late onset ataxias. Acta Neurol Scand 1990; 82: 225–229.CrossRefGoogle Scholar
37.Grossman, A, Rosenberg, R, Warmoth, L. Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology 1987; 37: 106–111.CrossRefGoogle ScholarPubMed
38.Rosenberg, R, Banner, C. Normal cerebellar glutamate dehydrogenase protein in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry 1989; 52: 666–668.CrossRefGoogle ScholarPubMed
39.Chokroverty, S, Nicklas, W, Miller, D, et al.Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry. J Neurol Neurosurg Psychiatry 1990; 53: 1099–1101.CrossRefGoogle ScholarPubMed